Literature DB >> 35699385

Quantiles based personalized treatment selection for multivariate outcomes and multiple treatments.

Karunarathna B Kulasekera1, Chathura Siriwardhana2.   

Abstract

In this work, we propose a method for individualized treatment selection when there are correlated multiple responses for the K treatment ( K ≥ 2 ) scenario. Here we use ranks of quantiles of outcome variables for each treatment conditional on patient-specific scores constructed from collected covariate measurements. Our method covers any number of treatments and outcome variables using any number of quantiles and it can be applied for a broad set of models. We propose a rank aggregation technique for combining several lists of ranks where both these lists and elements within each list can be correlated. The method has the flexibility to incorporate patient and clinician preferences into the optimal treatment decision on an individual case basis. A simulation study demonstrates the performance of the proposed method in finite samples. We also present illustrations using two different datasets from diabetes and HIV-1 clinical trials to show the applicability of the proposed procedure for real data.
© 2022 John Wiley & Sons Ltd.

Entities:  

Keywords:  design variables; personalized treatments; quantiles of outcomes; rank aggregation; single index models

Mesh:

Year:  2022        PMID: 35699385      PMCID: PMC9232994          DOI: 10.1002/sim.9377

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.497


  23 in total

1.  Aging cognition: from neuromodulation to representation.

Authors:  Shu Chen Li; Ulman Lindenberger; Sverker Sikström
Journal:  Trends Cogn Sci       Date:  2001-11-01       Impact factor: 20.229

2.  Biomarkers and surrogate endpoints in clinical trials.

Authors:  Thomas R Fleming; John H Powers
Journal:  Stat Med       Date:  2012-06-18       Impact factor: 2.373

3.  Identifying a set that contains the best dynamic treatment regimes.

Authors:  Ashkan Ertefaie; Tianshuang Wu; Kevin G Lynch; Inbal Nahum-Shani
Journal:  Biostatistics       Date:  2015-08-03       Impact factor: 5.899

4.  Set-valued dynamic treatment regimes for competing outcomes.

Authors:  Eric B Laber; Daniel J Lizotte; Bradley Ferguson
Journal:  Biometrics       Date:  2014-01-08       Impact factor: 2.571

5.  Selection of the optimal personalized treatment from multiple treatments with multivariate outcome measures.

Authors:  Chathura Siriwardhana; Somnath Datta; K B Kulasekera
Journal:  J Biopharm Stat       Date:  2019-11-06       Impact factor: 1.051

6.  Multi-Objective Markov Decision Processes for Data-Driven Decision Support.

Authors:  Daniel J Lizotte; Eric B Laber
Journal:  J Mach Learn Res       Date:  2016-12-01       Impact factor: 3.654

Review 7.  Vascular complications of diabetes: mechanisms of injury and protective factors.

Authors:  Christian Rask-Madsen; George L King
Journal:  Cell Metab       Date:  2013-01-08       Impact factor: 27.287

8.  Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules.

Authors:  Emily L Butler; Eric B Laber; Sonia M Davis; Michael R Kosorok
Journal:  Biometrics       Date:  2017-07-25       Impact factor: 1.701

9.  Optimization of personalized therapies for anticancer treatment.

Authors:  Alexei Vazquez
Journal:  BMC Syst Biol       Date:  2013-04-12

Review 10.  Importance of achieving the composite endpoints in diabetes.

Authors:  Ambika Gopalakrishnan Unnikrishnan; Arpandev Bhattacharyya; Manash Pratim Baruah; Binayak Sinha; Mala Dharmalingam; Paturi V Rao
Journal:  Indian J Endocrinol Metab       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.